Metabolic Syndrome
Conditions
Brief summary
To study the effects of Hesperidin supplement in patients with metabolic syndrome, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.
Interventions
DIETARY_SUPPLEMENThesperidin
500 mg hesperidin as two capsuls
OTHERcontrol
no supplementation
Sponsors
National Nutrition and Food Technology Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Age of 18 to 70 years * having 3 of 5 of high blood sugar, hypertension, high TG, high waist circumference, low HDL
Exclusion criteria
* pregnancy or lactation * A history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease; Cirrhosis * Following program to lose weight in recent 3 mo
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Metabolic syndrome: Number of participants with treated metabolic syndrome | 12 weeks | number of participants with treated metabolic syndrome |
Countries
Iran
Contacts
Primary Contactazita Hekmatdoost, MD.PhD
Outcome results
None listed